Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
19 June 2020 : Clinical Research
DOI: 10.12659/MSM.923015
Med Sci Monit 2020; 26:e923015
Figure 1 The dose-response relationship between VO2max and non-alcoholic fatty liver disease (NAFLD) risk.
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.
